FIRST MANHATTAN CO. LLC. - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2021$0–330.0%0.00%–
Q3 2021$0–330.0%0.00%–
Q2 2021$0–330.0%0.00%–
Q1 2021$0–330.0%0.00%–
Q4 2020$0–330.0%0.00%–
Q3 2020$0–330.0%0.00%–
Q2 2020$0–330.0%0.00%–
Q1 2020$0–330.0%0.00%–
Q4 2019$0–330.0%0.00%–
Q3 2019$0–330.0%0.00%–
Q2 2019$0–330.0%0.00%–
Q1 2019$0–330.0%0.00%–
Q4 2018$0–33
-8.3%
0.00%–
Q3 2018$0–360.0%0.00%–
Q2 2018$0–360.0%0.00%–
Q1 2018$0–360.0%0.00%–
Q4 2017$0–360.0%0.00%–
Q3 2017$0–360.0%0.00%–
Q2 2017$0–360.0%0.00%–
Q1 2017$0–36–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2021.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders